Viking Therapeutics (VKTX) Earnings Date, Estimates & Call Transcripts $52.56 +0.93 (+1.80%) (As of 09:45 AM ET) Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Viking Therapeutics Latest Earnings SummaryUpcoming Q4 Earnings DateFeb. 5EstimatedActual EPS (Oct. 23) -$0.22 Beat By $0.02 Consensus EPS (Oct. 23) -$0.24 Viking Therapeutics issued Q3 2024 earnings on October 23, 2024, reporting an EPS of -$0.22, which topped the consensus estimate of -$0.24 by $0.02. With a trailing EPS of -$0.93, Viking Therapeutics' earnings are expected to decrease next year, from ($0.98) to ($1.44) per share. Conference Call TranscriptConference Call AudioVKTX Upcoming EarningsViking Therapeutics' next earnings date is estimated for Wednesday, February 5, 2025, based off prior year's reporting schedules. Get Viking Therapeutics Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Viking Therapeutics and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataVKTX Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.VKTX Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Colonial MetalsA “Thank You Gift” From Pres. Trump - GeniusThe "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. A tax-free gift so powerful it could reshape the financial destinies of millions of IRA and 401(k) owners…Claim your FREE 2024 Gold Guide Viking Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20243-$0.27-$0.25-$0.26Q2 20243-$0.28-$0.17-$0.24Q3 20243-$0.29-$0.23-$0.26Q4 20243-$0.27-$0.24-$0.25FY 202412-$1.11-$0.89-$1.02Q1 20251-$0.28-$0.28-$0.28Q2 20251-$0.28-$0.28-$0.28Q3 20251-$0.30-$0.30-$0.30Q4 20251-$0.29-$0.29-$0.29FY 20254($1.15)($1.15)($1.15) Viking Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks 2/5/2025(Estimated)------- 10/23/2024Q3 2024-$0.24-$0.22+$0.02-$0.22-- 7/24/2024Q2 2024-$0.26-$0.20+$0.06-$0.20-- 4/24/2024Q1 2024-$0.27-$0.26+$0.01-$0.26-- 2/7/2024Q4 2023-$0.25-$0.25--$0.25-- 10/25/2023Q3 2023-$0.22-$0.23 -$0.01-$0.23-- 7/26/2023Q2 2023-$0.21-$0.19+$0.02-$0.19-- Get the Latest News and Ratings for VKTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Viking Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 4/26/2023Q1 2023-$0.24-$0.25 -$0.01-$0.25-- 2/8/2023Q4 2022-$0.23-$0.26 -$0.03-$0.26-- Viking Therapeutics Earnings - Frequently Asked Questions When is Viking Therapeutics's earnings date? Viking Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, February 5th, 2025 based off last year's report dates. Learn more on VKTX's earnings history. Did Viking Therapeutics beat their earnings estimates last quarter? In the previous quarter, Viking Therapeutics (NASDAQ:VKTX) reported ($0.22) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.24) by $0.02. Learn more on analysts' earnings estimate vs. VKTX's actual earnings. How can I listen to Viking Therapeutics's earnings conference call? The conference call for Viking Therapeutics's latest earnings report can be listened to online. Listen to Conference Call How can I read Viking Therapeutics's conference call transcript? The conference call transcript for Viking Therapeutics's latest earnings report can be read online. Read Transcript How much profit does Viking Therapeutics generate each year? Viking Therapeutics (NASDAQ:VKTX) has a recorded net income of -$85.89 million. VKTX has generated -$0.93 earnings per share over the last four quarters. What is Viking Therapeutics's EPS forecast for next year? Viking Therapeutics's earnings are expected to decrease from ($0.98) per share to ($1.44) per share in the next year. ` More Earnings Resources from MarketBeat Related Companies Prothena Earnings Results Puma Biotechnology Earnings Results Marinus Pharmaceuticals Earnings Results Teva Pharmaceutical Industries Earnings Results BeiGene Earnings Results Viatris Earnings Results Moderna Earnings Results Summit Therapeutics Earnings Results Genmab A/S Earnings Results Dr. Reddy's Laboratories Earnings Results Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Alibaba Stock: Why Earnings Make It a Buy Despite the Recent DipMercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?Roblox Stock Soars 22% After Q3 Earnings – A Turning Point Ahead?Apple Earnings - When Really Good Just Isn’t Good Enough Roblox Stock Set for More Gains After Strong Earnings ReportAmazon: Why Analysts Think It's a Solid Buy Ahead of EarningsLam Research Proves Analysts Wrong with a Strong Earnings Report A “Thank You Gift” From Pres. Trump - Genius (Ad)The "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. A tax-free gift so powerful it could reshape the financial destinies of millions of IRA and 401(k) owners…Claim your FREE 2024 Gold Guide This page (NASDAQ:VKTX) was last updated on 11/22/2024 by MarketBeat.com Staff From Our PartnersA “Thank You Gift” From Pres. Trump - GeniusTrump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax...Colonial Metals | SponsoredBuffett Dumps $982 Million in BofA Stock—What Does He Know?Buffett's been eerily quiet about his reasons, but his actions speak volumes. When someone with his track reco...Genesis Gold Group | Sponsored[Urgent] Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it a...Paradigm Press | SponsoredCentral Bank Abandons USDYou know what doesn't care about elections? Gold. If you want to protect your savings & retirement from our...Desko Digital | Sponsored[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | SponsoredWhat Comes Next Could Be a Once-in-a-Lifetime OpportunityA wave of technological and financial transformation is reshaping the investment landscape. For those who unde...InvestorPlace | SponsoredBREAKING: NVDA loses $175 billion in 8 minutesIt's a wild week for the legendary chipmaker. Nvidia just beat earnings expectations across every metric, w...Chaikin Analytics | SponsoredThe AI Crash Begins November 30thMost AI stocks are doomed. I’m not an AI hater. AI will absolutely continue to be the most disruptive tech...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Viking Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Viking Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
